Boundless Bio (BOLD) Shares Outstanding (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Shares Outstanding (Entity) of $22.4 million for Q1 2026, little changed year-over-year from $22.3 million in Q1 2025, and little changed quarter-over-quarter from $22.4 million in Q4 2025.
Boundless Bio (BOLD) Shares Outstanding (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Shares Outstanding (Entity) for 4 consecutive years, with $22.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) changed 0.48% year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (changed 0.48% YoY), while the FY2025 annual figure was $22.4 million, up 31.93% from the prior year.
- Shares Outstanding (Entity) steadied at $22.4 million in Q1 2026 per BOLD's latest filing, from $22.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $22.4 million in Q4 2025 and bottomed at $1.2 million in Q1 2023.
- Historically, Shares Outstanding (Entity) has averaged $13.8 million across 4 years, with a median of $22.3 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) surged 1734.16% — and 2026, when it gained 0.48%.
- Boundless Bio's Shares Outstanding (Entity) stood at $1.2 million in 2023, then surged by 1261.98% to $17.0 million in 2024, then surged by 31.93% to $22.4 million in 2025, then changed by 0.0% to $22.4 million in 2026.
- Business Quant data shows BOLD's Shares Outstanding (Entity) at $22.4 million in Q1 2026, $22.4 million in Q4 2025, and $22.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 445.06 Mn |
| 10 | Boundless Bio | 67.13 Mn | 67.13 Mn | - | 22.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.45 Mn |
| Mar 31, 2026 | 22.41 Mn |
| Dec 31, 2025 | 22.36 Mn |
| Sep 30, 2025 | 22.39 Mn |
| Jun 30, 2025 | 22.36 Mn |
| Mar 31, 2025 | 22.30 Mn |
| Dec 31, 2024 | 16.98 Mn |
| Sep 30, 2024 | 22.25 Mn |
| Jun 30, 2024 | 22.02 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.23 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.18 Mn |